Amgen in Advanced Talks to Buy Horizon Therapeutics, Sources Say — WSJ
Takeover of Rare-Disease Drugmaker Could Be Finalized by Monday, Sources Say — WSJ
Deal Would Likely Value Horizon at Well Over $20 Billion — WSJ
$AMGN $HZNP
Amgen in Advanced Talks to Buy Horizon Therapeutics, Sources Say — WSJ
Takeover of Rare-Disease Drugmaker Could Be Finalized by Monday, Sources Say — WSJ
Deal Would Likely Value Horizon at Well Over $20 Billion — WSJ
$AMGN $HZNP